Quazepam is a DEA Schedule IV controlled substance. Substances in the DEA Schedule IV have a low potential for abuse relative to substances in Schedule III. It is a Depressants substance. It is grouped under the following drug class(es): Benzodiazepines, Hypnotics and Schedule IV controlled substances. Its therapeutic use is listed as sleeping drugs. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Doral and Selepam. It is listed as a controlled drug substance (Schedule IV). Its PubChem CID is 4999.
Quazepam
| CAS No | 36735-22-5 |
|---|---|
| Molecular Formula | C17H11ClF4N2S |
| Molecular Weight | 386.8 g/mol |
| Synonyms | 7-chloro-5-(2-fluorophenyl)-1-(2,2,2-trifluoroethyl)-3H-1,4-benzodiazepine-2-thione |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Quazepam is a DEA Schedule IV controlled substance. Substances in the DEA Schedule IV have a low potential for abuse relative to substances in Schedule III. It is a Depressants substance.
The listed CAS number is 36735-22-5.
The listed molecular formula is C17H11ClF4N2S.
The listed molecular weight is 386.8 g/mol.
7-chloro-5-(2-fluorophenyl)-1-(2,2,2-trifluoroethyl)-3H-1,4-benzodiazepine-2-thione.
The source lists Doral and Selepam.